News Secretive Moderna could finally go public with $500m IPO RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.
Partner Content Partner Content New collaboration will advance human-based drug evaluation Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety
Partner Content Partner Content Overcoming bottlenecks in early drug discovery with the powe... Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry
News Amgen invests £50m in UK genetics firm Oxford Nanopore Biotech giant Amgen has ploughed £50 million into a genetic sequencing company to support the development of its cutting-edge technology.
News Crescendo hires ex-Roche R&D guru to develop T-cell technolo... Biotech has already raised $70m this year in second funding round
R&D UK regenerative medicine biotech appoints veteran 'drug hunt... Biotech aims to wake up stem cells with small molecules to repair damaged tissues
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.